Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ana Paula Cancino"'
Autor:
Carel le Roux, Vanita Aroda, Joanna Hemmingsson, Ana Paula Cancino, Rune Christensen, Xavier Pi-Sunyer
Publikováno v:
Obesity Facts, Vol 10, Iss 6, Pp 531-544 (2017)
Objective: To investigate whether the efficacy and safety of liraglutide 3.0 mg differed between two subgroups, BMI 27 to Methods: A post-hoc analysis of two 56-week, randomized, double-blind, placebo-controlled trials (SCALE Obesity and Prediabetes;
Externí odkaz:
https://doaj.org/article/8c5f8d6e8fce4cfabea0e1d79c775d92
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mette Bøgelund, Maria Høy, Maria Elmegaard Madsen, Francesco Rubino, Ana-Paula Cancino, Ulrik Haagen Panton, Jennifer Logue
Publikováno v:
Obesity Science & Practice, Vol 7, Iss 6, Pp 659-668 (2021)
Obesity Science & Practice
Obesity Science & Practice
Background and rationale Obesity is associated with the development and progression of many diseases. Understanding and management of obesity have become increasingly important; however, a knowledge gap remains between how healthcare providers (HCPs)
Autor:
Mary Fletcher-Louis, François Pattou, Fiachra Bolger, Ulrik Haagen Panton, Javier Salvador, Katrin Nather, Ana-Paula Cancino, Laurie DiModica
Publikováno v:
Clinical Obesity
Summary Obesity is a risk factor for severe complications from coronavirus disease 2019 (COVID‐19). During the COVID‐19 pandemic in Spring 2020, many clinics and obesity centers across Europe were required to close. This study aimed to determine
Autor:
Stephen C. Bain, Cecilie Yssing, Ulrik Haagen Panton, Matthew Capehorn, Maria Elmegaard Madsen, Annabell Cajus McMillan, Sébastien Czernichow, Ana-Paula Cancino, Mette Bøgelund
Publikováno v:
Clinical Obesity
Summary Excess weight is associated with severe outcomes of coronavirus disease 2019 (COVID‐19). We aimed to estimate the total secondary care costs by body mass index (BMI, kg/m2) category when hospitalized due to COVID‐19 in Europe during the f
Autor:
Joanna Uddén Hemmingsson, Rune Christensen, Vanita R. Aroda, Xavier Pi-Sunyer, Ana Paula Cancino, Carel W. le Roux
Publikováno v:
Obesity Facts, Vol 10, Iss 6, Pp 531-544 (2017)
Objective: To investigate whether the efficacy and safety of liraglutide 3.0 mg differed between two subgroups, BMI 27 to Methods: A post-hoc analysis of two 56-week, randomized, double-blind, placebo-controlled trials (SCALE Obesity and Prediabetes;
Autor:
Francesco Rubino, Jennifer Logue, Mette Bøgelund, Maria Elmegaard Madsen, Ana‐Paula Cancino, Maria Høy, Ulrik Haagen Panton
Publikováno v:
Obesity Science & Practice, Vol 7, Iss 6, Pp 659-668 (2021)
Abstract Background and rationale Obesity is associated with the development and progression of many diseases. Understanding and management of obesity have become increasingly important; however, a knowledge gap remains between how healthcare provide
Externí odkaz:
https://doaj.org/article/4ae74efcf2ee479cbdd037ec49b8df71